PDCD1 and lymphoma: Many studies have shown a significant increase in the numbers of PD-1+ TILs in lymphomas, including cHL (Muenst et al., 2009), DLBCL (Ahearne et al., 2014; Kwon et al., 2016), and follicular lymphoma (Smeltzer et al., 2014).